| Literature DB >> 33304651 |
Stanislas Kandelman1,2, Jérémy Allary1, Raphael Porcher3, Cássia Righy4,5, Clarissa Francisca Valdez4,6, Frank Rasulo7,8, Nicholas Heming9, Guy Moneger9, Eric Azabou10, Guillaume Savary1, Djillali Annane9, Fabrice Chretien11, Nicola Latronico7,8, Fernando Augusto Bozza5,12, Benjamin Rohaut13,14, Tarek Sharshar11,12,15.
Abstract
BACKGROUND: Deep sedation may hamper the detection of neurological deterioration in brain-injured patients. Impaired brainstem reflexes within the first 24 h of deep sedation are associated with increased mortality in non-brain-injured patients. Our objective was to confirm this association in brain-injured patients.Entities:
Keywords: Brain injury; Brainstem dysfunction; Cough reflex; Critical care; Deep sedation; Neurological examination; Neuroprognosis
Year: 2020 PMID: 33304651 PMCID: PMC7700733 DOI: 10.7717/peerj.10326
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flow chart.
Characteristics of patients and ICU outcome.
| Variable | All patients | TBI | Vascular | Other | |
|---|---|---|---|---|---|
| No. patients (% of total) | 137 | 70 (51) | 40 (29) | 27 (20) | |
| Age (years)—median (IQR) | 137 | 50 (34 to 63) | 39 (25 to 53) | 60 (52 to 66) | 53 (40 to 77) |
| Female—no. (%) | 137 | 56 (41) | 16 (23) | 27 (68) | 13 (50) |
| SAPS-II—median (IQR) | 129 | 46 (36 to 55) | 41 (33 to 53) | 48 (38 to 52) | 51 (44 to 60) |
| Initiation of mechanical ventilation—no. (%) | 137 | ||||
| Coma | 120 (88) | 68 (97) | 34 (85) | 18 (67) | |
| Acute respiratory failure | 6 (4) | 0 (0) | 2 (5) | 4 (15) | |
| Shock | 1 (1) | 0 (0) | 0 (0) | 1 (4) | |
| Surgery/procedure | 6 (4) | 0 (0) | 4 (10) | 2 (7) | |
| Other | 4 (3) | 2 (3) | 0 (0) | 2 (7) | |
| McCabe score 1—no. (%) | 135 | 106 (79) | 64 (93) | 22 (55) | 20 (77) |
| GCS at admission—median (IQR) | 132 | 7 (4 to 10) | 7 (5 to 10) | 7 (4 to 10) | 6 (3 to 11) |
| SOFA at admission—median (IQR) | 132 | 6 (4 to 8) | 5 (4 to 8) | 5 (4 to 7) | 7 (4 to 9) |
| Outcome | |||||
| Duration of mechanical Ventilation (days)—median (IQR) | 131 | 13 (8 to 24) | 14 (10 to 23) | 13 (8 to 20) | 9 (5 to 23) |
| Duration of sedative infusion (days)—median (IQR) | 133 | 5 (3 to 10) | 5 (3 to 12) | 4 (3 to 11) | 4 (3 to 7) |
| Occurrence of elevated intracranial pressure—no. (%) | 103 | 50 (49) | 31 (48) | 16 (50) | 3 (43) |
| Occurrence of ventilator acquired pneumonia—no. (%) | 135 | 86 (64) | 50 (72) | 25 (62) | 11 (42) |
| Time to awakening (days)—median (IQR) | 131 | 4 (1 to 12) | 4 (1 to 12) | 6 (2 to 17) | 1 (0 to 5) |
| Occurrence of delayed awakening—no. (%) | 131 | 67 (51) | 36 (51) | 23 (64) | 8 (32) |
| Occurrence of delirium—no. (%) | 112 | 66 (59) | 46 (75) | 12 (40) | 8 (38) |
| Duration of ICU stay (days)—median (IQR) | 136 | 19 (11 to 32) | 19 (11 to 32) | 20 (12 to 36) | 15 (8 to 24) |
| Death in ICU—no. (%) | 137 | 30 (22) | 12 (17) | 11 (28) | 7 (26) |
Notes:
N, number of evaluated patients; SAPS II, Simplified Acute Physiology Score; GCS, Glasgow Coma Scale; SOFA, sepsis related organ failure assessment; ICU, Intensive Care Unit; TBI, Traumatic brain injury; IQR, Interquartile range (Q1 to Q3).
Patients who died while sedated could not be evaluated.
Patients who died while sedation or before awakening could not be evaluated.
Neurological assessment at inclusion.
| Variable | All patients | TBI | Vascular | Other | |
|---|---|---|---|---|---|
| No. patients (% of total) | 137 | 70 (51) | 40 (29) | 27 (20) | |
| RASS-5—no. (%) | 137 | 90 (66) | 54 (77) | 21 (52) | 15 (56) |
| Neurologic response | |||||
| GCS motor—median (IQR) | 124 | 1 (1 to 1) | 1 (1 to 1) | 1 (1 to 2) | 1 (1 to 3) |
| GCS ocular—median (IQR) | 124 | 1 (1 to 1) | 1 (1 to 1) | 1 (1 to 1) | 1 (1 to 1) |
| FOUR Score—median (IQR) | 111 | 4 (2 to 5) | 4 (2 to 5) | 4 (2 to 5) | 4 (2 to 7) |
| Eye response—median (IQR) | 113 | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 0) |
| Motor response—median (IQR) | 113 | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 0) | 0 (0 to 2) |
| Brainstem reflexes—median (IQR) | 111 | 4 (2 to 4) | 4 (2 to 4) | 4 (2 to 4) | 3 (2 to 4) |
| Respiration—median (IQR) | 113 | 0 (0 to 1) | 0 (0 to 1) | 0 (0 to 1) | 1 (0 to 1) |
| Brainstem reflexes impairment | |||||
| Pupillary light reflex—no. (%) | 134 | 55 (41) | 29 (42) | 19 (49) | 7 (27) |
| Corneal reflex—no. (%) | 131 | 28 (21) | 15 (23) | 7 (18) | 6 (23) |
| Grimacing to pain—no. (%) | 108 | 76 (70) | 51 (86) | 14 (48) | 11 (55) |
| Cough reflex—no. (%) | 135 | 35 (16) | 19 (28) | 9 (22) | 7 (27) |
| Myosis—no. (%) | 136 | 69 (51) | 37 (54) | 19 (48) | 13 (48) |
Note:
N, number of evaluated patients; IQR, Interquartile range (Q1 to Q3); RASS, Richmond Assessment Sedation Scale; GCS, Glasgow Coma Scale; FOUR score, Full outline of Unresponsiveness; TBI, Traumatic brain injury.
Comparison of sedation according to the presence/absence of cough reflex.
| Cough reflex | |||
|---|---|---|---|
| Present | Absent | ||
| No. patients | 100 | 35 | |
| Hypnotic agent (several possible) | |||
| Midazolam—no. (%) | 86 (86) | 34 (97) | 0.11 |
| Propofol—no. (%) | 25 (25) | 10 (29) | 0.66 |
| Thiopental—no. (%) | 1 (1) | 4 (11) | 0.016 |
| Midazolam dose (mg/Kg)—median (IQR) | 1.2 (0.7 to 2.1) | 1.9 (1.2 to 2.3) | 0.005 |
| Propofol dose (mg/Kg)—median (IQR) | 17.7 (10.2 to 22.6) | 37.1 (18.4 to 44.4) | 0.12 |
| Morphinic agent—no. (%) | 0.60 | ||
| No | 4 (4) | 0 (0) | |
| Sufentanyl | 78 (78) | 27 (77) | |
| Fentanyl | 18 (18) | 8 (23) | |
| Morphinic dose (µg/Kg) | 3.9 (2.2 to 7.4) | 6.7 (3.8 to 10.3) | 0.006 |
| SAPS-II—median (IQR) | 46 (36 to 55) | 46 (34 to 55) | 0.76 |
| SOFA at admission—median (IQR) | 5 (4 to 8) | 6 (5 to 8) | 0.27 |
| RASS-5—no. (%) | 60 (60) | 28 (80) | 0.039 |
Notes:
IQR, Interquartile range (Q1 to Q3); Sedation and analgesics doses are cumulative doses from introduction to neurological assessment (12–24 h); two patients were excluded from this analysis, for missing sedation data.
Sufentanyl-equivalent dose (for the 18% of patients which received fentanyl, doses where divided by 10).
Association of neurological response with ICU death.
| Unadjusted | Multiple model 1 | Multiple model 2 | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | aOR (95% CI) | aOR (95% CI) | ||||
| SAPS-II (per unit) | 1.06 [1.02–1.09] | 0.002 | 1.04 [1.00–1.08] | 0.086 | 1.04 [0.99–1.08] | 0.092 |
| GCS at admission (per unit) | 0.80 [0.69–0.93] | 0.004 | 0.88 [0.74–1.04] | 0.13 | 0.87 [0.72–1.04] | 0.12 |
| RASS-5 | 1.58 [0.64–3.91] | 0.32 | 0.74 [0.26–2.17] | 0.59 | – | – |
| Midazolam dose (mg/Kg) | 0.69 [0.44–1.11] | 0.12 | – | – | 0.42 [0.14–1.25] | 0.12 |
| Morphinic dose (μg/Kg) | 0.97 [0.88–1.08] | 0.59 | – | – | 1.01 [0.82–1.25] | 0.91 |
| Absent cough reflex | 5.12 [2.13–12.4] | 0.0003 | 5.19 [1.92–14.1] | 0.001 | 8.89 [2.64–30.0] | 0.0004 |
| Absent corneal reflex | 2.69 [1.08–6.68] | 0.034 | 1.71 [0.57–5.10] | 0.34 | 1.66 [0.54–5.08] | 0.38 |
| 0.810 [0.726–0.893] | 0.852 [0.773–0.931] | |||||
Notes:
Sufentanyl-equivalent dose.
OR, odds ratio; aOR, adjusted odds ratio; SAPS II, Simplified Acute Physiology Score; RASS, Richmond Assessment Sedation Scale.